title: Drug therapy in the heart transplant recipient: part IV: drug-drug interactions.
authors.affiliation: Department of Clinical Pharmacy, University of Colorado Health Sciences Center, Denver, Colo 80262, USA.
authors.forename: Robert L
authors.initials: RL
authors.lastname: Page
authors.forename: Geraldine G
authors.initials: GG
authors.lastname: Miller
authors.forename: JoAnn
authors.initials: J
authors.lastname: Lindenfeld
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000493:pharmacokinetics; D000928:Antidepressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics; D001692:Biological Transport; D001711:Biotransformation; D002317:Cardiovascular Agents / Q000009:adverse effects / Q000493:pharmacokinetics; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004347:Drug Interactions; D016027:Heart Transplantation / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000145:classification / Q000493:pharmacokinetics* / Q000627:therapeutic use; D008657:Metabolic Clearance Rate; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000890:Anti-Infective Agents; D000928:Antidepressive Agents; D002317:Cardiovascular Agents; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors; D003577:Cytochrome P-450 Enzyme System